(Q33404875)

26 July 2017

title

Phase II study of bendamustine in relapsed and refractory Hodgkin lymphoma (English)

1 reference

26 July 2017

1 reference

1 reference

Matthew J Matasar

6

0 references

Andrew D Zelenetz

Andrew D Zelenetz

12

0 references

Ariela Noy

Ariela Noy

7

0 references

Paul Hamlin

Paul A Hamlin

2

0 references

Steven M Horwitz

5

Steven M Horwitz

1 reference

26 July 2017

1

Alison J Moskowitz

1 reference

26 July 2017

Miguel-Angel Perales

3

1 reference

26 July 2017

John Gerecitano

4

1 reference

26 July 2017

Maria Lia Palomba

8

1 reference

26 July 2017

Carol S Portlock

9

1 reference

26 July 2017

David J Straus

10

1 reference

26 July 2017

Tricia Graustein

11

1 reference

26 July 2017

Craig H Moskowitz

13

1 reference

26 July 2017

language of work or name

English

0 references

publication date

17 December 2012

1 reference

Journal of Clinical Oncology

26 July 2017

published in

1 reference

26 July 2017

volume

31

1 reference

26 July 2017

issue

4

1 reference

26 July 2017

page(s)

456-460

1 reference

A phase 2 multicenter study of lenalidomide in relapsed or refractory classical Hodgkin lymphoma

26 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3862960

The Role of Allogeneic Stem Cell Transplantation in Relapsed/Refractory Hodgkin's Lymphoma Patients

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3862960

Outcomes for patients who fail high dose chemoradiotherapy and autologous stem cell rescue for relapsed and primary refractory Hodgkin lymphoma

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3862960

Gemcitabine, vinorelbine, and pegylated liposomal doxorubicin (GVD), a salvage regimen in relapsed Hodgkin's lymphoma: CALGB 59804.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3862960

Metabolism and mechanisms of action of bendamustine: rationales for combination therapies

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3862960

Donor lymphocyte infusions modulate relapse risk in mixed chimeras and induce durable salvage in relapsed patients after T-cell-depleted allogeneic transplantation for Hodgkin's lymphoma.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3862960

Reduced intensity allogeneic hematopoietic cell transplantation can induce durable remission in heavily pretreated relapsed Hodgkin lymphoma

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3862960

Revised response criteria for malignant lymphoma

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3862960

Randomized comparison of ABVD and MOPP/ABV hybrid for the treatment of advanced Hodgkin's disease: report of an intergroup trial

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3862960

Pretransplantation [18-F]fluorodeoxyglucose positron emission tomography scan predicts outcome in patients with recurrent Hodgkin lymphoma or aggressive non-Hodgkin lymphoma undergoing reduced-intensity conditioning followed by allogeneic stem cell t

31 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23248254

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

New drugs in the treatment of Hodgkin's disease

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23248254

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1200/JCO.2012.45.3308

1 reference

26 July 2017

1 reference

26 July 2017

1 reference